Assessment of Cerebrospinal Fluid Flow Related Disorders Using a Phase-contrast Magnetic Resonance Imaging Technique.
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03656016 |
|
Recruitment Status :
Recruiting
First Posted : September 4, 2018
Last Update Posted : June 29, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Cerebrospinal Fluid | Device: Magnetic Resonance Imaging |
There are several disorders such as communicating and non- communicating hydrocephalus, normal pressure hydrocephalus, cystic cerebrospinal fluid collections, Chiari malformation, syringomyelic cyst and arachnoid cyst that can change the cerebrospinal fluid dynamics.
Rapid advances in imaging techniques have remarkably improved the diagnosis and treatment of these disorders.
Phase contrast magnetic resonance imaging is a rapid, simple and non-invasive technique which is sensitive to even small cerebrospinal fluid flows, and can be used to evaluate cerebrospinal fluid flow both qualitatively and quantitatively. Cine phase contrast magnetic resonance images show cerebrospinal fluid flow in a dynamic, more easily appreciable, and in a more pleasing manner, allowing the delineation of obstruction, if present, along the portions of cerebrospinal fluid pathway where obstruction is common.
Phase contrast magnetic resonance imaging can be used to discriminate between communicating hydrocephalus and non-communicating hydrocephalus, to localize the level of obstruction in obstructive hydrocephalus, to determine whether arachnoid cysts communicate with the subarachnoid space, to differentiate between arachnoid cysts and subarachnoid space, to discriminate between syringomyelia and cystic myelomalacia, and to evaluate flow patterns of posterior fossa cystic malformations.
This imaging method can also provide significant information in pre-operative evaluation of Chiari 1 malformation and post-operative follow-up of patients with neuroendoscopic third ventriculostomy and ventriculoperitoneal shunt.
The application of cine phase contrast magnetic resonance imaging technique in patients with normal pressure hydrocephalus holds great promise for improvement of the diagnosis, especially in those cases where the differentiation from atrophy on clinical and conventional radiological basis is difficult.
| Study Type : | Observational |
| Estimated Enrollment : | 87 participants |
| Observational Model: | Case-Control |
| Time Perspective: | Prospective |
| Official Title: | Assessment of Cerebrospinal Fluid Flow Related Disorders Using a Phase-contrast Magnetic Resonance Imaging Technique. |
| Actual Study Start Date : | November 25, 2018 |
| Estimated Primary Completion Date : | February 2022 |
| Estimated Study Completion Date : | June 2022 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
study group
patients with congenital and acquired disorders that can alter the CSF dynamics will undergo phase-contrast magnetic resonance imaging
|
Device: Magnetic Resonance Imaging
Phase contrast magnetic resonance imaging technique |
|
control group
age matched healthy individuals will undergo phase-contrast magnetic resonance imaging
|
Device: Magnetic Resonance Imaging
Phase contrast magnetic resonance imaging technique |
- To calculate different cerebrospinal fluid flow parameters at different levels of flow quantification. [ Time Frame: base line ]measure Systolic stroke volume and Peak systolic velocity at different levels of flow quantification
- To correlate these parameters to the normal values of age matched control group [ Time Frame: baseline ]correlate Systolic stroke volume and Peak systolic velocity with normal values
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Patients with different age groups and both sex with clinical and routine conventional magnetic resonance imaging findings suggestive of cerebrospinal fluid flow disorders.
Exclusion Criteria:
- Patients with contraindications for MRI, e.g. an implanted magnetic device, pacemakers or claustrophobia.
- Patients with VP shunts
- Patients with ventriculomegally due to brain SOLs.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03656016
| Contact: Mostafa Hussein | 01122999878 | thabet.mostafa@yahoo.com | |
| Contact: Hazem Youseif | 01005075888 | bozaidhazz@yahoo.com |
| Egypt | |
| Faculty of medicine | Recruiting |
| Assiut, Egypt, 71111 | |
| Contact: Mostafa Thabet, MD 01122999878 thabet.mostafa@yahoo.com | |
| Contact: Marwa Ahmed, MD 01006541595 drmarwa201198@ymail.com | |
| Principal Investigator: | Shimaa Bakr, MSc | Assiut University |
| Responsible Party: | Shimaa Hassanien Hassanien Bakr, principal Investigator, Assiut University |
| ClinicalTrials.gov Identifier: | NCT03656016 |
| Other Study ID Numbers: |
CSFFPCMRI |
| First Posted: | September 4, 2018 Key Record Dates |
| Last Update Posted: | June 29, 2021 |
| Last Verified: | June 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |

